Specifications
Anit-infective drugs,Anti cancer products

Characteristics
To elevate the CD4 quantity lr lymph cells ,lower the number of virus carrier of HIV infected patients.
To suppress the virus to duplicate
To strengthen the immunity,prolong the potential period,improve patients quality of liveing and lengthen their life.
Nonpoisonous and no any side effects
Indication
SAVir can ideally be used for the following patients:
Decreased CD4 quantity of lymph cells
Ratio lf CD4/CD8 is lower than 1.5(Normal value:1.5-2.0).
Decreased leucocytes and platelets.

.Reference resource: Click Here.

In an early-morning announcement today, researchers reported that an experimental HIV (human immunodeficiency virus) vaccine effectively reduced the number of people who contracted the virus by nearly a third.

Tested in a U.S.-sponsored trial that involved more than 16,000 volunteers in Thailand, the vaccine was administered in six injected doses starting in 2006 to half of the group, and the other half received a placebo. Seventy-four people in the placebo group had contracted HIV by the end of the trial, whereas only 51 of the vaccinated group tested positive.* The injections consisted of two vaccines that had proven unsuccessful on their own: Sanofi-Aventis SA’s ALVAC and VaxGen Inc.’s AIDSVAX.

.Reference resource: Click Here.